Increased Net Income
Net income for Q2 2025 was $0.54 per diluted share, up from $0.40 per diluted share in Q2 2024, driven by a $4.6 million increase in interest income.
Interest Income Growth
Interest income increased to $22.8 million in Q2 2025 from $18.2 million in Q2 2024, primarily due to increased income from investments.
Dividend Announcement
Declared a regular dividend of $0.50 per share for Q3 2025, consistent with Q2 2025.
Strong Portfolio Performance
The portfolio consists of 86 investments with a total outstanding balance of $1.1 billion, with significant allocations in multifamily and life science sectors.
Positive Market Outlook
Demand outperformed expectations with a national stabilized occupancy rate improved to 94.6% in July 2025, indicating an improving rental market.
Life Science Leasing Success
Successfully closing in on a 245,000 square foot lease with an AI biologics company, expected to enhance the Alewife project.